Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 7 studies | 41% ± 10% | |
respiratory goblet cell | 6 studies | 55% ± 20% | |
transit amplifying cell | 5 studies | 38% ± 17% | |
club cell | 4 studies | 48% ± 17% | |
deuterosomal cell | 4 studies | 24% ± 9% | |
epithelial cell | 4 studies | 38% ± 16% | |
intestinal crypt stem cell | 4 studies | 36% ± 15% | |
ciliated cell | 3 studies | 30% ± 7% | |
duct epithelial cell | 3 studies | 35% ± 28% | |
secretory cell | 3 studies | 55% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 19749.46 | 226 / 226 | 88% | 681.42 | 358 / 406 |
pancreas | 82% | 588.63 | 269 / 328 | 83% | 72.85 | 147 / 178 |
stomach | 89% | 6436.95 | 321 / 359 | 69% | 77.57 | 197 / 286 |
intestine | 84% | 5523.39 | 812 / 966 | 66% | 58.83 | 350 / 527 |
prostate | 83% | 656.17 | 203 / 245 | 49% | 9.21 | 245 / 502 |
breast | 99% | 1349.36 | 455 / 459 | 10% | 1.90 | 111 / 1118 |
bladder | 71% | 340.48 | 15 / 21 | 38% | 29.17 | 189 / 504 |
adipose | 96% | 1154.94 | 1150 / 1204 | 0% | 0 | 0 / 0 |
muscle | 94% | 933.30 | 758 / 803 | 0% | 0 | 0 / 0 |
esophagus | 58% | 366.90 | 834 / 1445 | 34% | 52.15 | 63 / 183 |
lung | 36% | 161.04 | 210 / 578 | 41% | 76.82 | 470 / 1155 |
uterus | 48% | 220.38 | 81 / 170 | 22% | 25.39 | 102 / 459 |
kidney | 63% | 334.85 | 56 / 89 | 6% | 4.08 | 52 / 901 |
ovary | 51% | 213.56 | 91 / 180 | 3% | 0.60 | 11 / 430 |
thymus | 42% | 160.80 | 277 / 653 | 2% | 0.60 | 13 / 605 |
heart | 36% | 137.31 | 313 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 30% | 149.10 | 404 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 17.46 | 8 / 45 |
peripheral blood | 8% | 99.61 | 77 / 929 | 0% | 0 | 0 / 0 |
skin | 6% | 19.98 | 115 / 1809 | 1% | 0.17 | 3 / 472 |
adrenal gland | 0% | 1.05 | 1 / 258 | 5% | 7.14 | 11 / 230 |
spleen | 1% | 27.32 | 2 / 241 | 0% | 0 | 0 / 0 |
brain | 0% | 1.63 | 13 / 2642 | 0% | 0.07 | 2 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0004024 | Molecular function | alcohol dehydrogenase (NAD+) activity, zinc-dependent |
GO_0004022 | Molecular function | alcohol dehydrogenase (NAD+) activity |
GO_0004745 | Molecular function | all-trans-retinol dehydrogenase (NAD+) activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ADH1C |
Protein name | Alcohol dehydrogenase 1C (EC 1.1.1.1) (Alcohol dehydrogenase subunit gamma) Alcohol dehydrogenase 1C (class I), gamma polypeptide |
Synonyms | ADH3 |
Description | FUNCTION: Alcohol dehydrogenase. Exhibits high activity for ethanol oxidation and plays a major role in ethanol catabolism. . |
Accessions | ENST00000510055.5 A0A087WU81 A0A087WUC4 ENST00000515683.6 P00326 ENST00000511397.3 |